Background. To 
Norepinephrine-mediated cell toxicity was attenuated significantly by ,-adrenoceptor blockade and mimicked by selective stimulation of the ,B-adrenoceptor, whereas the effects mediated by the a-adrenoceptor were relatively less apparent. When norepinephrine stimulation was examined in terms of cardiocyte anabolic activity, there was a concentration-dependent decrease in the incorporation of [3H]phenylalanine and [3H]uridine into cytoplasmic protein and nuclear RNA, respectively. The decrease in cytoplasmic labeling was largely attenuated by f-adrenoceptor blockade and mimicked by selective stimulation of the ,B-adrenoceptor, but a-adrenoceptor stimulation resulted in relatively minor decreases in cytoplasmic labeling. The norepinephrine-induced toxic effect appeared to be the result of cyclic AMP-mediated calcium overload of the cell, as suggested by studies in which pharmacological strategies that increased intracellular cyclic AMP led to decreased cell viability, as well as studies that showed that influx of extracellular calcium through the verapamil-sensitive calcium channel was necessary for the induction of cell lethality. Additional time-course studies showed that norepinephrine caused a rapid, fourfold increase in intracellular cyclic AMP, followed by a 3.2-fold increase in intracellular calcium ([Ca2+] 
i).
Conclusions. These results constitute the initial demonstration at the cellular level that adrenergic stimulation leads to cyclic AMP-mediated calcium overload of the cell, with a resultant decrease in synthetic activity and/or viability. (Circulation 1992; 85:790-804) It is well recognized that the sympathetic nervous system has a major role in the cardiovascular response to stress.' However, a number of studies have shown that excessive adrenergic stimulation can aggravate or even produce, rather than ameliorate, various manifestations of cardiovascular and, more recently, congestive heart failure. 6 Given the potential importance of catecholamine-mediated cardiotoxic effects in humans, a number of experimental studies have sought to determine the mechanism(s) responsible for catecholamine-induced cardiac injury.7-29 However, although these in vivo studies have yielded important insights into the genesis of catecholamine cardiotoxicity, no definitive mechanism has been identified.
One of the major problems in defining the mechanism(s) of catecholamine cardiotoxicity in vivo is the complex alterations in cardiac loading and blood flow inherent in all such in vivo experimental models. Thus, one cannot fully dissociate any direct toxic effects of the catecholamine from any concurrent cardiac injury that may be produced by mechanical overloading and/or ischemia. A second major prob-lem in defining these mechanism(s) results from the complexity of cardiac tissue, which comprises cardiac muscle cells, or cardiocytes, admixed with interstitial, neural, and vascular cells. Given that adrenergic stimulation could lead to multiple cell-cell interactions, it becomes very difficult to isolate and precisely define the direct biological effects of catecholamines on the cardiocyte component of the heart.
To provide a more focused approach to defining the proximate mechanism(s) causing catecholamineinduced toxicity, we used a very simple experimental preparation-the isolated cultured adult mammalian cardiocyte-to examine the direct effects of norepinephrine on the biology of this cell. The results of the present study directly support the view that catecholamine cardiotoxicity is the result of cyclic AMP (cAMP) -mediated calcium overload of the cardiocyte.
Methods

Cardiocyte Isolation
With the exceptions noted below, the methods used to obtain reproducible yields of calcium-tolerant cardiocytes have been described previously. 30 Briefly, adult cats of either sex, weighing 1.4-3.8 kg, were anesthetized with ketamine hydrochloride (50 mg/kg i.m.) and acepromazine maleate (5 mg/kg i.m.) and submitted to rapid cardiectomy under sterile conditions. The aorta was then cannulated, and the coronary arteries were perfused retrograde for 10 minutes with a recirculating modified KrebsHenseleit buffer (KHB) of the following composition (mm): NaCl 130.0, KCI 4.8, MgSO4 1.2, NaH2PO4 1.2, NaHCO3 4.0, CaCl2 0.5, HEPES 10.0, and glucose 12.5. This was followed by a nonrecirculating buffer of the same composition but without supplemental calcium and concluded with a nonrecirculating calcium-free buffer supplemented with type II collagenase (155 units/ml). Perfusion was terminated when the heart was flaccid. The heart was then removed from the cannula, the ventricles were separated from the atria, and the ventricular cardiocytes were isolated as described previously. 30 Cardiocyte Culture
The characteristics of the cell culture system used herein have been reported in detail. 30 An important feature of this model that bears emphasis is that adult feline cardiocytes remain quiescent (noncontracting) for extended periods of time when maintained in standard serum-free culture conditions. Indeed, the initiation of spontaneous contractions in these cells usually indicates that they have become nonviable. 31 Unless specified otherwise, the culture medium used was medium 199 (Earle's salts, 0.30 mM DL-phenylalanine, 1.8 mM calcium) supplemented with 10-6 M insulin, 6.25 ,g/ml transferrin, 6.25 ng/ml selenium, 5 .35 1£g/ml linoleic acid, 1.2 p£g/ml albumin, 100 units/ml penicillin, and 6.8x 10`M streptomycin. At each medium change, 100 /M ascorbic acid was added to retard oxidation of any added catecholamine. To minimize fibroblast contamination, selective adhesion techniques were used; fibroblast contamination is <2% with this method. 30 Cardiocytes were kept in a 37°C humidified incubator equilibrated with 5% CO2 to achieve a final medium pH of 7.30-7.35.
Experimental Protocols
To determine the effects of norepinephrine exposure in vitro, cell cultures were treated continuously for 72 hours with graded concentrations of adrenergic agonists and antagonists. The selected range of adrenergic agonist concentrations was based on previous reports that showed that such levels are attainable at the neural cleft or available as circulating levels under certain pathological conditions.32-34 For adrenergic antagonists, the selected concentrations were based on reported values,35,36 as well as on studies described below in which we determined the concentration of antagonist necessary to block the norepinephrine-mediated increase in cAMP.
A 2-ml suspension of freshly isolated cardiocytes was plated at a final concentration of 1x 104 cells/ml onto laminin-coated (20 ,ug/ml) coverslips in 35 mm polystyrene petri dishes. Beginning on the first day in culture, the cardiocytes were exposed continuously to concentrations of norepinephrine ranging from 10t o 10-6 M; each dish was treated with a single concentration of norepinephrine. Control cultures were treated with an equal volume of diluent. Medium changes were performed on the first and second days of culture, at which time freshly prepared adrenergic agents or a diluent was added. After 24 hours, the norepinephrine concentration as measured by high-performance liquid chromatography remained at least 80% of the original value. On the third day of culture, all dishes were labeled either with 40 ,Ci/ml [3H]phenylalanine or 5 ,uCi/ml [3H]uridine to determine their incorporation into cellular protein or nuclear RNA, respectively. In a second series of experiments, we examined the effect of norepinephrine on cardiocytes whose 13-and/or a-adrenoceptors were blocked before adrenergic stimulation. For these experiments, the cells were pretreated for 1 hour with the nonselective 13-antagonist propranolol (range, 10-9 to 10-6 M) or with the nonselective a-antagonist phentolamine (range, 10-8 to 10`M); for studies using combined ,B-and a-adrenergic blockade, the cells were pretreated for 1 hour with both 10-6 M propranolol and 10-5 M phentolamine. After adrenoceptor blockade, the cells were treated with 1 gM norepinephrine; the medium was changed on the first and second days in culture, and fresh solutions of adrenergic agonists and antagonists were applied. Each experimental set in this series comprised a negative control group treated with diluent only, a control group treated with the maximum concentration of adrenergic antagonist(s) used, and additional groups that received both 1 populations of cells using the tetracarboxylate calcium indicator fura-2, as well as in single cells using fluo-3. For the former studies, freshly isolated cardiocytes were plated onto laminin-coated plastic sleeves and maintained under sterile conditions for at least 24 hours before experimentation. On the day of study, the cardiocytes were washed in KHB, and the laminin-coated plastic sleeve containing the cardiocytes was fixed vertically at a 450 angle in a quartz cuvette containing 2 ml of KHB. Fluorescence measurements were performed using a fluorometer equipped with a xenon lamp and a water jacket that maintained the cells at 37°C. After 15 minutes of equilibration, the extent of cardiocyte autofluorescence was determined at an emission wavelength of 510 nm using excitation wavelengths of 340 and 380 nm. In control studies, we determined that the amount of autofluorescence from the plastic sleeve itself was negligible (<5%). The cells were loaded with 20 ,uM fura-2 acetomethoxy ester (AM) for 1 hour53 and then washed with KHB buffer to remove any extracellular fura-2 AM. After fura-2 loading, the cardiocytes were equilibrated for an additional 30 minutes to permit complete hydrolysis of any remaining intracellular acetomethoxy ester. The 4 mM fura-2 AM stock solutions were made in a DMSO vehicle and stored in a dark container at -70°C.
Adenosine tniphosphate measurements. Norepinephrine at a final concentration of 1 ,uM was added to the KHB, and the resulting change in cardiocyte fluorescence was measured continuously for 1 minute to identify the time course of any increase in [Ca2+]i.
After it was determined that no experiment involved very rapid transients, the emission spectrum was checked every 3 minutes for a total of 30 minutes. The brightness of the fura-2 emission signal at 510 nM was calculated using excitation spectra of 340 and 380 nM, and the level of [Ca21]i determined as the 340/380 ratio of fura-2 brightness54; these values were corrected for background autofluorescence as described by Bruschi et al. 53 Two additional experiments were done to better define the norepinephrine effect on [Ca21]i. First, the role of 8-adrenoceptor activation was assessed by repeating the above studies after pretreating the cells with 1 ,M propranolol for 1 hour. Second, to determine the role of influx of extracellular calcium, the cardiocytes were studied in a nominally calcium-free KHB buffer containing 1 mM EGTA. With the exceptions just noted, the conditions for the latter two studies were identical to those described above.
To better address the question of whether calcium influx preceded cell injury or whether instead cell injury was the primary event with secondary influx of calcium, the above studies were repeated in individual cells using digital imaging fluorescence microscopy. For the present study, we used a relatively new fluorophore, fluo-3, which has an excitation peak at 503-506 nm and an emission peak at 526 nm.55 Fluo-3 has two unique advantages over the traditional ultraviolet (UV) excited indicators. First, this fluorophore has a very large (-40- Norepinephrine at a final concentration of 1 ,M was added to the culture medium, and the resulting change in cardiocyte fluorescence was measured 30 minutes later. Control cells were treated with diluent. Fluorescent brightness was measured using a microspectrofluorometer equipped with a xenon bulb. The filter sets used delivered 490 nm excitation light; emission was measured using a barrier filter that passed light at wavelengths >520 nm. The resulting fluorescence image (x400) was analyzed by digital imaging microscopy, which integrates the intensity of fluorescence brightness over the surface area of an individual cardiocyte and then normalizes this value by the surface area of the cell (,am2); this accounted for any variations in fluorescence brightness that might occur on the basis of cell size alone (expressed as arbitrary units fluorescence brightness/gm2 cell).
Nonspecific background fluorescence was eliminated by a background subtraction routine; autofluorescence was not detectable at the low visible light levels used in the present study.
Two additional fluorescence microscopy experiments were done to further define the norepinephrine effect on [Ca2"]i. First, the role of ,B-adrenoceptor activation was assessed by repeating the above experiments after pretreating the cells with 1 ,uM propranolol for 1 hour. Second, to determine the role of influx of extracellular calcium, the cardiocytes were pretreated with 1 ,M verapamil for 1 hour, and the above experiments were repeated. With the exceptions just noted, the conditions for the latter two experiments were identical to those described above.
To be certain that norepinephrine-mediated hypercontracture that followed the induction of spontaneous cardiocyte beating was the result of calcium overloading of the cell and not simply the result of excessive mechanical stimulation, we performed an additional control study in which cell viability was assessed after electrical stimulation at a frequency similar to that of the norepinephrine-induced spontaneous beating. For these experiments, freshly isolated cardiocytes were continuously paced electrically for 30 minutes with a pair of platinum wire electrodes using 0.33-Hz, 100-,A DC pulses of alternating polarity with no voltage offset between pulses; the latter two stimulation conditions were used to minimize electrolysis. The percentage of viable rod-shaped cardiocytes was determined before and 30 minutes after continuous pacing. The extent of creatine kinase release was measured at 24 hours in the cultures that were electrically stimulated, as well as in a group of control cultures that were not electrically stimulated.
To determine whether the norepinephrine-mediated toxic effect was secondary to ATP depletion, we measured intracellular ATP levels in vitro. Preparation and maintenance of the cultures were exactly as described above. On the first day in culture, the cells were stimulated with 1 gm norepinephrine for 0, 15, and 60 minutes and 24 hours; the appropriate control groups for this experiment consisted of parallel cultures treated at identical time points with diluent only. At the end of each indicated time point, the cultures were washed three times with cold KHB buffer and intracellular ATP extracted for 10 minutes with cold 12% trichloroacetic acid. The samples were then ether-extracted five times, and the pH was adjusted to 7.8. Intracellular levels of ATP were measured using the luciferease assay according to the method of Lundin et al. 56, 57 The amount of cellular protein per sample was determined using the bicinchoninic assay. 58 The level of ATP in the norepinephrine and control cultures was expressed in nanomoles of ATP per milligram of cardiocyte protein. 
Statistical Analysis
Each value is expressed as mean±SEM. Specific adrenergic agonist and antagonist effects on cell viability were examined by two-way ANOVA, with testing for differences within experimental groups on the second and third days in culture. One-way ANOVA was used to test for overall differences in the extent of [3H]phenylalanine or [3H]uridine incorporation in norepinephrine-treated cells; where appropriate, Dunnett's multiple comparison59 was used to test for specific differences between control and experimental groups. A difference was said to be significant at p<0.05.
Results
Cell Viability
An important finding of the present study was that norepinephrine stimulation led to a striking, concentration-dependent decrease in cardiocyte viability. That is, when rod-shaped cardiocytes were exposed to norepinephrine, a large proportion of these normally quiescent cells began to contract spontaneously within 15-30 minutes. When followed over time, virtually all such cells developed irreversible hypercontracture. Figure 1 (upper panel) shows the morphology of a rod-shaped cardiocyte and (lower panel) of a hypercontracted cardiocyte exposed to 1 ,uM norepinephrine. Figure 2 summarizes third day in culture. As shown, 1 jaM propranolol greatly attenuated but did not fully prevent the toxic effect of norepinephrine. Thus, in an additional experiment the cells were pretreated with both 1 ,uM propranolol and 10 ,uM phentolamine before norepinephrine treatment. Figure 3B shows that combined a-and 83-adrenoceptor blockade completely prevented the norepinephrine-mediated decrease in cell viability. Figure 4 summarizes the second pharmacological approach, in which cells were treated with phenylephrine or isoproterenol to study the respective effects of either a-or ,B-adrenoceptor stimulation on cardiocyte viability. Panel A of Figure 4 shows that phenylephrine treatment resulted in a very small but significant decline in the percentage of rod-shaped cardiocytes; Figure 4 shows that isoproterenol stimulation caused an obvious decrease in the percentage of rod-shaped cells; this effect was very similar to the norepinephrine effect shown in Figure 1 . Indeed, two-way ANOVA showed that the isoproterenol effect was both concentration and time dependent (p<0.001).
To confirm that the decline in the number of rod-shaped cells reflected diminished cell viability, we measured the amount of creatine kinase release in cardiocyte cultures treated for 24 hours with 10t o 10-5 M norepinephrine. Figure 5 shows that there was a stepwise increase in creatine kinase release as a function of increasing norepinephrine concentration. ANOVA indicated that these overall differences in creatine kinase release were statistically significant (p<0.001); post-ANOVA comparison indicated that there were significant differences from control for norepinephrine concentrations .10`7 M.
Linear regression analysis was also done to determine whether there was a relation between the norepinephrine-mediated decrease in cell viability and the amount of creatine kinase release. This analysis showed that after exposure to 10-9 to 10-5 M norepinephrine for 24 hours, there was a significant To be certain that norepinephrine-mediated cardiocyte toxicity was not a strictly species-dependent phenomenon, we repeated these studies using cells isolated from adult rat and canine hearts. Figure 5 shows that norepinephrine treatment led to an overall significant (p<0.001 for both) release of creatine kinase from both rodent and canine cardiocytes, albeit to a lesser extent in the rat. For canine cardiocytes, post-ANOVA testing indicated that there were significant differences from control for norepinephrine concentrations > 10`M, whereas for rodent cardiocytes there were significant differences for norepinephrine concentrations > 10-M. Biochemistry Adrenergic effects on cardiocyte synthetic activity were assessed in two separate autoradiographic studies of [3H]phenylalanine incorporation into cytoplasmic proteins and [3H]uridine incorporation into nuclear RNA.
Protein labeling. A second important finding of the present study was that continuous stimulation with norepinephrine resulted in a concentration-dependent decrease in [3H]phenylalanine incorporation into viable rod-shaped cardiocytes. Figure 6 shows the results of exposing cardiocytes for 72 hours to norepinephrine concentrations ranging from 10`to 10`6 M. The salient finding is the striking decrease in cytoplasmic labeling with increasing norepinephrine Each value is expressed as the mean±SEM of the percent change from control in the extent of cytoplasmic labeling. For each of the treatments noted above, the data were obtained from a minimum of 100 consecutively studied rod-shaped cardiocytes; nonviable ball-shaped cardiocytes were excluded from the analysis.
Norepinephrine treatment (1 lM) led to a significant decline in the extent of cytoplasmic labeling. One-way ANOVA indicated that propranolol exerted a significant concentration-dependent "sparing" of the norepinephrine-mediated decrease in [3H]phenylalanine incorporation; at 10-6 M propranolol, the effects of norepinephrine were largely, but not completely, attenuated. There was, however, no significant concentration-dependent "sparing" effect after pretreatment with phentolamine. The combination of 10-5 M phentolamine and 10-6 M propranolol fully blocked the norepinephrine-mediated effects on cardiocyte protein synthesis. Treatment concentrations. ANOVA indicated that these overall differences were significant (p<0.001); Dunnett's post-ANOVA comparison showed that this catecholamine-mediated effect was significantly different from control for norepinephrine concentrations >10-8 M. Table 1 is a summary of the results of autoradiographic studies in which cells were exposed to norepinephrine in the presence of a-and/or f3-adrenergic antagonists. The extent of cytoplasmic protein labeling was expressed as a percentage of control. When the cells were pretreated with concentrations of propranolol ranging from i0`to 10-6 M, there was a concentration-dependent amelioration of the norepinephrine-mediated decrease in protein labeling. Nevertheless, the norepinephrine effect was still evident in the cells treated with 1 ,uM propranolol, albeit to a much lesser extent. In contrast to the findings with ,3-adrenoceptor blockade, phentolamine did not appreciably block the norepinephrinemediated decrease in [3H]phenylalanine incorporation. However, the combination of a-and f3-adrenoceptor blockade completely blocked the norepinephrine-mediated reduction in cytoplasmic labeling.
To further define the mechanism(s) for catecholamine-mediated effect(s) on protein synthesis, we studied the effects of a-or /8-adrenoceptor agonists on cytoplasmic protein labeling. Table 2 shows that 72 hours of continuous exposure to 10-10 to 10-7 M isoproterenol caused a concentration-dependent decrease in cytoplasmic labeling that was similar to the norepinephrine effect. ANOVA showed that these overall differences were highly significant (p<0.001); Dunnett's post-ANOVA testing indicated that this effect was significantly different from control for isoproterenol concentrations >10-10 M. In contrast to the findings with selective ,B-adrenoceptor stimulation, exposure to phenylephrine caused a small but significant (p<0.05) decrease in [3H]phenylalanine incorporation. Dunnett's post-ANOVA testing showed that the phenylephrine effect was not significantly different from control until very large concentrations (10-`M) were used. Blockade of the phenylephrine-treated cells with 10 ,uM phentolamine prevented the decrease in cytoplasmic labeling.
RNA labeling. Table 3 shows the effects of 72 hours of continuous norepinephrine treatment on cardiocyte nuclear RNA labeling. There was a decrease in nuclear labeling as a function of increasing norepinephrine concentration. ANOVA showed that the overall differences were significant (p<0.001); post- Catecholamine-Mediated Toxicity: In Vitro Mechanisms cAMP elevation. Table 4 summarizes the results of the three studies showing that cAMP elevation induced spontaneous cardiocyte beating that, over time, led to the cell hypercontracture depicted in Figures 1 and 2 . Although a range of concentrations was tested for each agent shown in Table 4 , for the sake of simplicity only the lowest drug concentration that produced the indicated effect is reported. First, the use of 10-`M 2'5'-dideoxyadenosine to block cAMP production prevented induction of spontaneous beating by 1 ,M norepinephrine. Second, when cAMP production was stimulated through a non-,8-adrenoceptor mechanism by 10`6 M forskolin, spontaneous cardiocyte beating occurred within 30 minutes. Third, when 10-3 M dibutyryl cAMP, a cAMP analogue, was added to the culture dishes, the cells began to beat spontaneously within 60 minutes. Figure 7 shows the results of studies in which the time course of cAMP elevation was measured after stimulation with 1 ,M norepinephrine. There was a sustained fourfold increase in cAMP production after norepinephrine stimulation. Furthermore, pretreatment with 1 .M propranolol for 60 minutes largely abolished the norepinephrine-induced increase in cAMP.
Calcium influx. Table 4 also is a summary of the results of studies of the role of calcium influx in inducing spontaneous cardiocyte beating and hypercontracture. Although a range of concentrations was tested for each agent, only the lowest drug concentration that produced the indicated effect is reported. First, although norepinephrine-induced spontaneous beating was readily induced in cardiocytes in 2.5 mM calcium buffer, this was not seen in norepinephrinestimulated cells in a calcium-free 10`M EGTA buffer. Furthermore, the absence of norepinephrineinduced spontaneous beating in the EGTA-treated cells was not secondary to damage to cell membranes because the EGTA-treated cells began to contract spontaneously when placed in a 2.5 mM calcium solution and restimulated with 1 ,M norepinephrine.
Second, both verapamil (.1 ,M) and cobalt chloride (.10 mM) suppressed spontaneous beating completely at concentrations that block the slow calcium channel.48,60 Third, neither 10 ,uM tetrodotoxin nor Each value is expressed as mean±SEM. Day 1 cultures were exposed to one or more treatments as detailed in the left column, and the percentage of spontaneously contracting cells was quantified 30 minutes after stimulation; however, for dibutyryl cyclic AMP, the percentage of spontaneously contracting rods was quantified 60 minutes after stimulation. For each of the studies detailed above, either the induction or the complete inhibition of spontaneous beating was used as the physiological end point. Although a range of concentrations was tested for each agent, only the lowest drug concentration that produced the indicated effect is reported in the left column. Contracting rods were quantified in five randomly picked fields (x 200 magnification) per dish, using a minimum of eight dishes for each concentration of drug tested. Unless specified, agents were always applied to the cells for a period of 30 minutes; control cells received diluent only. The concentration of norepinephrine used throughout these studies was 1 gM. As shown, experimental conditions that are known to increase cyclic AMP led to the development of spontaneous beating. This norepinephrine-mediated effect could be prevented by removing extracellular calcium or blocking the slow calcium channel; pharmacological blockade of the fast sodium channel had no effect on the induction of spontaneous beating. C.)
A cells) or 1 ,um verapamil (0.10±0.004, n=100 cells). An additional important finding of the present study was that norepinephrine caused rhythmic "scintillations" of fluorescence brightness within individual cells that were quite similar in appearance to the rhythmic flashing of the firefly Photuris versicolor on a summer evening. This phenomenon, which is illustrated in Figure 9 , was seen in the majority of rodshaped cardiocytes at various times after norepinephrine stimulation. Furthermore, although not every cell showing rhythmic scintillations developed spontaneous beating, this phenomenon was always observed in cells in which spontaneous beating developed. Although the present study was not designed to elucidate the mechanism(s) for this interesting finding, the rhythmic increase in fluorescence brightness probably represents calcium-triggered calcium release from the sarcoplasmic reticulum. 61 Mechanical stimulator. Adenosine triphosphate measurements. Table 5 is a summary of the results of the studies in which we examined the effect of norepinephrine stimulation on intracellular ATP levels. As shown, there was no change in the intracellular levels of ATP in either the control or the norepinephrine-treated cultures. Twoway ANOVA showed that there were no significant differences between groups (p=0.99) or within groups as a function of time of treatment (p=0.97).
Discussion
The present study directly supports the hypothesis that cAMP-mediated calcium overload is the primary mechanism responsible for catecholamine-induced toxicity in cultured adult mammalian cardiocytes. Two distinct lines of evidence support this statement. First, when the effects of adrenergic stimulation were examined in virtually pure populations of cardiocytes using concentrations of norepinephrine that are normally attainable at the neural cleft32 or available as actual circulating levels in certain pathological conditions,6,33,34 there was both a concentration-dependent decrease in cardiocyte viability, as shown by a striking decrease in viable rod-shaped cells, and a significant release of creatine kinase. The view that these effects were mediated directly by the f3-adreno- ceptor is supported by the finding that the toxic effects of norepinephrine were attenuated significantly by f-adrenoceptor blockade and mimicked by selective stimulation of the P-adrenoceptor. In contrast, a-adrenoceptor effects were relatively small and evident only when very large concentrations of a-adrenergic agonists and antagonists were used. It is of some interest that the toxic response to norepinephrine was not confined to a single mammalian species; toxicity was elicited in rat, cat, and -canine cardiocytes. Of note, toxicity was evident for rat cardiocytes only when very large concentrations of norepinephrine were used, probably reflecting the relatively smaller number of /-adrenoceptors in this species compared with cat, dog, and humans. [62] [63] [64] Second, continuous adrenergic stimulation led to cAMP-mediated calcium overload of the cardiocyte, as shown indirectly by pharmacological strategies in which increased intracellular cAMP was shown to cause spontaneous beating and cell hypercontracture, as well by data showing that calcium influx through the verapamil-sensitive calcium channel was necessary for this effect. The role of cAMP-mediated calcium influx is supported more directly by the microspectrofluorometric studies, as well as by the time course studies where norepinephrine exposure led first to a rapid fourfold increase in intracellular cAMP and then to a 3.2-fold increase in [Ca2"],. Furthermore, the norepinephrine effects on cAMP and [Ca2+]i were significantly attenuated by P-adrenoceptor blockade, as might be expected from the relation between f,-adrenoceptor stimulation and activation of the verapamil-sensitive calcium channel.46w47 To be certain that cardiocyte hypercontracture was the result of calcium overload of the cell rather than excessive mechanical activity, an additional control experiment was performed in which the cells were electrically stimulated to contract. When the cells were stimulated at a frequency similar to that seen with norepinephrine exposure, there was no significant decrease in the number of viable rod-shaped cells or significant increase in creatine kinase release from the paced cells. Finally, to exclude the possibility that calcium influx into the cell was secondary to depletion of high-energy phosphates rather than a direct effect of norepinephrine, we measured intracellular ATP levels in vitro. These results showed that intracellular ATP levels were unchanged when norepinephrine stimulation resulted in cAMP-mediated calcium overload of the cell. Parenthetically, it should be noted that the experimental protocols detailed were designed to minimize the effects of free radicals in culture; therefore, it is not possible to comment on any potential effects that free radicals might have played in the observed catecholamine-mediated toxic effects in our in vitro model. Nevertheless, on the basis of the present study, it would be premature to comment on rates of protein or RNA synthesis or degradation, given that size of the phenylalanine and uridine pools were not known.
Experimental Catecholamine Cardiotoxicity
In 1959, Rona et a17 made the important observation that injection of isoproterenol into rats produces "infarctlike" myocardial necrosis in the absence of significant coronary artery lesions. This observation led to the suggestion that "relative hypoxia" was responsible for the observed cardiac necrosis.7-9,65 That is, increased cardiac inotropy and chronotropy after adrenergic stimulation caused a relative imbalance between myocardial oxygen demand and blood flow, such that demand exceeded supply. In support of this view is the observation that isoproterenol decreases coronary blood flow in the early phase of isoproterenol cardiotoxicity.10 In addition to this relative hypoxia theory, a number of alternative hypotheses have been proposed to explain catecholamineinduced myocardial injury. Rona and coworkersl1-'4 also suggested that catecholamine-mediated increases in sarcolemmal permeability contributed to the pathogenesis of myocardial injury. Although the concept of calcium-induced cardiac necrosis had been introduced previously,66 Fleckenstein'5 was the first to propose the radically different concept that calcium overload of the cell was the result of catecholamine-mediated cell injury. According to this theory, the important event in the development of the catecholamine-mediated lesion was a high-energy phosphate deficiency that resulted from excessive activation of calcium-dependent ATPases and calcium-induced impairment of mitochondrial function. Critical support for the calcium overload hypothesis followed in an important study by Bloom and Davis17 that showed that myocardial calcium increased 10 minutes after injection of isoproterenol into rats, suggesting that calcium influx was the cause rather than the consequence of cardiac injury.'6 Although Bloom and Sweat67 subsequently showed that increased levels of myocardial calcium were coupled to elevations in myocardial cAMP, the view that cellular calcium overload was consequent to /8-adrenoceptor-mediated elevations of cAMP was first suggested by Bhagat et al. 18 This hypothesis was subsequently confirmed in a series of studies by Opie and colleagues,19,20,24 who demonstrated in Langendorff rat hearts that catecholamine injury was mediated by the /-adrenoceptor. However, the importance of the ,B-adrenoceptor was not confirmed by an in vivo study in rabbits, which suggested instead that catecholamine cardiotoxicity is largely mediated by the a-adrenoceptor. 21, 22 Finally, others have suggested that oxidative catecholamine metabolites and/or the formation of oxygen or oxygenderived free radicals causes cardiac damage. [25] [26] [27] [28] However, as noted in a recent review,29 the biological significance of these latter studies is uncertain given the large concentrations of adrenochrome (2 10-M) needed to cause cardiac injury. Thus, a number of hypotheses have been proposed, but there is no consensus regarding the basic mechanism(s) responsible for catecholamine cardiotoxicity.
Conclusions
The toxic cardiac effects of catecholamines have been recognized at least since 1907, when Josue68 first reported catecholamine-induced cardiac necrosis. Thus, we were not surprised to find that norepinephrine caused toxic effects in isolated adult cardiocytes. This statement notwithstanding, the importance of the present study is twofold. First, this simple experimental study provides straightforward and compelling evidence in support of the viewpoint that cAMPmediated calcium overload of the cell is a fundamentally important early event in the genesis of catecholamine-induced cardiac injury. Second, the present study constitutes the initial demonstration that socalled "pathological" elevations of norepinephrine lead to a concentration-dependent decrease in cardiocyte RNA and protein synthetic activity, as well as cell viability.
Although direct correlations between short-term effects in isolated cells and long-term effects in the heart in vivo are not appropriate, these data do provide several potential clinical insights. For example, the prognosis of patients with congestive heart failure is inversely related to the level of circulating plasma norepinephrine.56 Although this catecholamine response may well be an effect of disease severity, it may also have a deleterious contributory role. Furthermore, our finding that catecholamineinduced calcium overload occurs predominately via the f3-adrenoceptor suggests a mechanism for the salutary clinical effect of (8-blockade in dilated cardiomyopathy.69-71 Finally, our finding that adrenergic stimulation causes decreased cardiocyte synthetic activity suggests a potential mechanism, albeit speculative, for the progressive pump dysfunction in patients with dilated cardiomyopathy. That is, the norepinephrine-induced decrease in cardiocyte RNA and protein synthesis may compromise the development of fully compensatory hypertrophy in response to some forms of chronic cardiac stress. In summary, catecholamines have a major, and beneficial, role in the short-term cardiovascular response to physiological stress. Unfortunately, during the long-term cardiovascular response to pathological stress, the beneficial role of catecholamines may occur at the price of superimposed cardiac toxicity.
